Resource Center
Resource Center
A recent article published in the Global Health: Science and Practice journal details successful efforts to reduce maternal and neonatal mortality in the South Africa, including adaptations to the program during the first 19 months of the COVID-19 pandemic.
Read more
CHAI welcomes new board member, Ms. Ophelia Dahl, co-founder of Partners In Health
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Around the world, 2.5 billion people need assistive products and services. Yet nearly one billion of them are denied access, particularly in low- and middle-income countries, where access can be as low as 3 percent of the need for these life-changing products. For children, this can mean a lifetime of being left behind. CHAI is...
Read more
Ahead of plans to introduce the hepatitis B vaccine, CHAI Cameroon piloted integrating tuberculosis and polio vaccinations within 24-hours of child birth.
Read more
As part of a growing portfolio of biomedical HIV prevention options, long-acting injectable cabotegravir (CAB-LA) was approved by the US FDA in December 2021. Evidence from two clinical trials, HPTN 083 and HPTN 084, which enrolled nearly 8,000 participants across 13 countries (including 7 countries in sub-Saharan Africa), demonstrated that CAB-LA is safe and highly...
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
New test-and-treat consortium to quickly provide Ministries of Health in 10 low- and middle-income countries with oral antiviral treatments to high-risk patients and scale up wider access through 2023.
Read more
A critical second-line HIV treatment called darunavir/ritonavir (DRV/r) is rolling out across Nigeria and Zambia – some of the earliest adopters of many countries that can now access an affordable supply of these medicines following a pricing agreement secured by CHAI and Unitaid last year.
Read more
With CHAI support, Nasarawa State in Nigeria has rolled out integrated hepatitis C and HIV testing.
Read more